Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Teriflunomide”

61 trials

Showing 20 of 61 results

Large-scale testing (Phase 3)Study completedNCT00622700
What this trial is testing

Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 618
Testing effectiveness (Phase 2)Study completedNCT04056897
What this trial is testing

Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biocad 271
Testing effectiveness (Phase 2)Study completedNCT00228163
What this trial is testing

Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Who this might be right for
Multiple Sclerosis
Sanofi 147
Not applicableUnknownNCT04676204
What this trial is testing

Relationship Between Oral DMT Burden and Adherence in MS

Who this might be right for
Multiple SclerosisAdherence, Medication
Monash University 323
Testing effectiveness (Phase 2)WithdrawnNCT06176235
What this trial is testing

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital
Large-scale testing (Phase 3)Study completedNCT03122652
What this trial is testing

Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome

Who this might be right for
Multiple Sclerosis
Centre Hospitalier Universitaire de Nice 125
Large-scale testing (Phase 3)Study completedNCT04410991
What this trial is testing

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)

Who this might be right for
Relapsing Multiple Sclerosis
Sanofi 899
Large-scale testing (Phase 3)Study completedNCT02425644
What this trial is testing

Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis

Who this might be right for
Multiple Sclerosis
Actelion 1,133
Not applicableActive Not RecruitingNCT03368677
What this trial is testing

Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression

Who this might be right for
Multiple Sclerosis
Turku University Hospital 26
Testing effectiveness (Phase 2)Study completedNCT04806737
What this trial is testing

Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease

Who this might be right for
Celiac Disease
Oslo University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00475865
What this trial is testing

Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 123
Not applicableStudy completedNCT03526224
What this trial is testing

Teriflunomide Tecfidera LMCE

Who this might be right for
TecfideraTeriflunomide
University at Buffalo 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05147220
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,000
Large-scale testing (Phase 3)Study completedNCT00883337
What this trial is testing

A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 324
Large-scale testing (Phase 3)Active Not RecruitingNCT05156281
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,007
Testing effectiveness (Phase 2)Looking for participantsNCT07065968
What this trial is testing

The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 132
Testing effectiveness (Phase 2)Study completedNCT00489489
What this trial is testing

Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 118
Not applicableNot Yet RecruitingNCT06843382
What this trial is testing

Real-world Experience of Oral Agents On Fatigability in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
TC Erciyes University 100
Large-scale testing (Phase 3)Study completedNCT02201108
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Genzyme, a Sanofi Company 166
Testing effectiveness (Phase 2)UnknownNCT06190145
What this trial is testing

Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation